Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
6,580.00
-40.00 (-0.60%)
At close: Jul 11, 2025, 3:30 PM KST
Jin Yang Pharmaceutical Revenue
Jin Yang Pharmaceutical had revenue of 30.94B KRW in the quarter ending March 31, 2025, with 13.34% growth. This brings the company's revenue in the last twelve months to 116.97B, up 18.58% year-over-year. In the year 2024, Jin Yang Pharmaceutical had annual revenue of 113.33B with 20.94% growth.
Revenue (ttm)
116.97B
Revenue Growth
+18.58%
P/S Ratio
0.67
Revenue / Employee
531.70M
Employees
220
Market Cap
78.87B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 113.33B | 19.62B | 20.94% |
Dec 31, 2023 | 93.71B | 17.44B | 22.87% |
Dec 31, 2022 | 76.26B | 13.43B | 21.36% |
Dec 31, 2021 | 62.84B | 13.31B | 26.88% |
Dec 31, 2020 | 49.52B | 2.17B | 4.59% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.10T |
SK hynix | 71.40T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hyundai Motor Company | 178.98T |
KB Financial Group | 14.93T |
Celltrion | 3,662.23B |
Kia Corporation | 109.25T |